German pharmaceutical company Bayer has agreed to acquire Whitehouse Station, N.J.-based Merck & Co.’s OTC consumer care business for $14.2 billion. In 2013, 70 percent of Merck’s OTC consumer care ...

Bayer announced today that it will acquire Merck's non-prescription and consumer care business for $14.2 billion, a move that will make Bayer the second biggest drug-maker in the world after Johnson & ...

TRENTON, N.J. (AP) — Germany’s Bayer plans to buy Merck & Co.’s consumer health business, creating a combined medicine cabinet of household names from Bayer’s aspirin to Merck’s Claritin allergy pills ...

This week, Bayer announced first-quarter 2025 results. Novo Nordisk and GSK plc announced licensing deals with smaller biotechs. The FDA granted approval to Merck's drug, Welireg, for its third ...

Bayer and Merck & Co, Inc. said heart-failure drug candidate vericiguat didn't meet the primary target of a late-stage study. The German conglomerate on Monday said vericiguat in the phase 3 Victor ...